REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Neiroprodzhekt OOO (Russia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Neiroprodzhekt OOO Profile Updated: August 17, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

Neiroprodzhekt OOO is based in Russia. The head office is in Moscow. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on February 03, 2003. From the latest financial highlights, Neiroprodzhekt OOO reported a net sales revenue drop of 23.47% in 2023. A growth of 16.18% was recorded in its total assets. In 2023, Neiroprodzhekt OOO’s net profit margin decreased by 1.57%.

Headquarters
Korovinskoe, 10, 2, 1 Pom 101
Moscow; Moscow; Postal Code: 127486

Contact Details: Purchase the Neiroprodzhekt OOO report to view the information.

Website: http://stereotaxy.ru

Basic Information
Outstanding Shares:
Purchase the Neiroprodzhekt OOO report to view the information.
Registered Capital:
Purchase the Neiroprodzhekt OOO report to view the information.
Incorporation Date:
February 03, 2003
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Purchase this report to view the information.
18.75%
Purchase this report to view the information.
15%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Neiroprodzhekt OOO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
-23.47%▼
Total operating revenue
-23.47%▼
Operating profit (EBIT)
-30.3%▼
Net Profit (Loss) for the Period
-28.85%▼
Total assets
16.18%▲
Total equity
-17.58%▼
Operating Profit Margin (ROS)
-2.61%▼
Net Profit Margin
-1.57%▼
Return on Equity (ROE)
-15.19%▼
Quick Ratio
-2.39%▼
Cash Ratio
-2.82%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo